Upsher-Smith Laboratories Inc. will have three poster presentations at the American Epilepsy Society’s 70th annual meeting, running through Tuesday in Houston. Read More »

Baxter International recently presented data regarding the SHARESOURCE remote patient management platform and the AMIA automated peritoneal dialysis system and their roles in more efficient home dialysis while supporting patients and their ability to be independent. Read More »

Baxter International recently presented its research on extracorporeal blood purification and its role in the removing of molecules associated with inflammation at the American Society of Nephrology’s annual Kidney Week. Read More »

The Data Safety Monitoring Board has awarded Onxeo S.A. with its ninth unanimous recommendation. Read More »

Bayer has formed a Phase 3 clinical trial that will assess the safety and effectiveness of Nifurtimox, a formulation designed to treat children of all ages that have been diagnosed with Chagas disease. Read More »

CSL Behring's Phase 2b clinical trial involving AEGIS-I has turned in positive results. Read More »

Akcea Therapeutics' Phase 1/2 trial involving IONIS-ANGPTL3-LRx has turned in positive results. Read More »

Merck has received the R&D 100 Award from R&D magazine. Read More »

McKesson Specialty Health hosted its two-day 2016 Onmark Fall Leadership Summit in Orlando, Florida, featuring the possible transformation that community oncology practices are having to make so they can survive in the ever-evolving world of care based on value and payment reform. Read More »

Merck KGaA will present the data on its investigational drug for the treatment of systemic lupus erythematosus ataciept at the 2016 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting. Read More »

Amgen's results of its Phase 3 coronary intravascular imaging trial, call GLAGOV, will be presented at the American Heart Association Scientific Sessions 2016. Read More »

ACADIA Pharmaceuticals' Phase II SERENE trial involving pimavanserin has begun. Read More »

Valeant Pharmaceuticals and Progenics Pharmaceuticals have commercially released RELISTOR Tablets in the United States and it is now available for prescription. Read More »

Acella Pharmaceuticals was recently approved to begin the development of a generic form of a sugar-free Bromfed DM cough syrup. Read More »

Cidara Therapeutics' data from its CD101 preclinical and clinical trials was presented at the 2016 American College of Clinical Pharmacy annual meeting and at the IDWeek 2016 meeting last month. Read More »